Impact of the Addition of Metformin to Abiraterone in Pre-docetaxel Metastatic Castration-resistant Prostate Cancer Patients Progressing on Abiraterone Treatment (MetAb-Pro): a Phase II Pilot Study
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Abiraterone (Primary) ; Metformin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms METAB-PRO
- 07 Jun 2017 Biomarkers information updated
- 09 Sep 2014 ClinicalTrials.gov record states the change of patient population from "post-docetaxel" to "pre-docetaxel" metastatic castration-resistant prostate cancer patients, it is reflected in the official title also.
- 09 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.